11/4/2022
Celiac Disease Foundation Partners with Anokion on Phase 1b/2 Study of KAN-101
The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.
Continue Reading